Bodey Gp
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
-
- Antibiotic Resistance in Bacteria
Papers in
- Oncology 17
- Neutropenia and Cancer Infections 8
- Cancer Treatment and Pharmacology 4
- Epidemiology 14
- Neuroendocrine Tumor Research Advances 4
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Rodríguez (3 shared papers)Burgess Ma (7 shared papers)Manuel Valdivieso (8 shared papers)KB McCredie (2 shared papers)Fernando Cabanillas (2 shared papers)Jean Latreille (1 shared paper)Alfred Distefano (1 shared paper)B Rosenbaum (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (42 papers)
- Partner nations
- United States
In The Last Decade
Bodey Gp
40 papers receiving 453 citations
Peers
Comparison fields: 5 of 79
- Infectious Diseases 165
- Molecular Medicine 33
- Oncology 171
- Clinical Biochemistry 35
- Hematology 46
Countries citing papers authored by Bodey Gp
This map shows the geographic impact of Bodey Gp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodey Gp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodey Gp more than expected).
Fields of papers citing papers by Bodey Gp
This network shows the impact of papers produced by Bodey Gp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodey Gp. The network helps show where Bodey Gp may publish in the future.
Co-authors
The 25 scholars most cited alongside Bodey Gp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Candidiasis in cancer patients. | 1984 | 168 |
| 2 | Therapy of infections with the combination of carbenicillin and gentamicin. | 1969 | 34 |
| 3 | Approaches to the treatment of acute leukemia and lymphoma in adults. | 1978 | 33 |
| 4 | Cytotoxic chemotherapy in adrenal cortical carcinoma. | 1981 | 29 |
| 5 | Infectious complications of acute leukemia. | 1966 | 24 |
| 6 | Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy. | 1980 | 20 |
| 7 | Phase II study of anguidine in advanced breast cancer. | 1979 | 18 |
| 8 | Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma. | 1980 | 14 |
| 9 | Pneumocystis carinii pneumonitis in cancer patients. | 1972 | 13 |
| 10 | Phlebitis associated with cephalosporins: cephapirin versus cephalothin. | 1973 | 12 |
| 11 | Phase I evaluation of oral tegafur. | 1983 | 10 |
| 12 | Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II). | 1978 | 9 |
| 13 | High-dose AMSA and bone marrow rescue in patients with solid tumors. | 1982 | 9 |
| 14 | Phase I-II evaluation of cyclocytidine. | 1977 | 8 |
| 15 | Combination 6-mercaptopurine and 6-methylmercaptopurine riboside in the treatment of adult acute leukemia: a Southwest Oncology Group study. | 1979 | 8 |
| 16 | Phase I study of L-alanosine using a daily x 3 schedule. | 1982 | 8 |
| 17 | Antimicrobial prophylaxis for infection in neutropenic patients. | 1988 | 8 |
| 18 | Neocarzinostatin: report of a phase II clinical trial. | 1981 | 7 |
| 19 | Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer. | 1981 | 7 |
| 20 | Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma. | 1980 | 7 |
About Bodey Gp
Bodey Gp is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Infectious Diseases and Molecular Biology, having authored 43 papers that have together received 512 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (8 papers), Lung Cancer Treatments and Mutations (7 papers), Antifungal resistance and susceptibility (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Infectious Diseases (165 citations), Molecular Medicine (33 citations), Oncology (171 citations), Clinical Biochemistry (35 citations) and Hematology (46 citations). Bodey Gp has collaborated with scholars based in United States. Frequent co-authors include Rodríguez, Burgess Ma, Manuel Valdivieso, KB McCredie, Fernando Cabanillas, Jean Latreille, Alfred Distefano, B Rosenbaum, Benjamin Lichtiger and Frank C. Schell. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.